Virtual Audits

Duration: 60 minutes

Webinar Recording

First Name (Required)

Last Name (Required)

Business Email (Required)

Company (Required)

Job Title (Required)

Phone Number

Where are you located? (Required)

State (Required)

GDPR Please tick this box to consent to our privacy policy.

Opt-In Please tick this box if you agree to receive periodic updates from PharmaLex. You can unsubscribe at any time at data.protection@pharmalex.com.

Comments

If you do not wish to receive any communication from us, you may unsubscribe at any time. Click here to view our privacy policy.

Why watch

Summary

The webinar on Virtual Audits will present the current regulatory expectations, benefits and challenges of virtual auditing and will share expertise on the planning, preparation, performance and reporting for a virtual audit.

Key Learnings

Are virtual audits the way forward after Covid 19
What are the key differences between an onsite and virtual audit and how to bridge the gaps
What are the key considerations in building an audit plan based on Virtual Audits

speakers

A full day of inspirational speakers

Proud to bring inspirational speakers from across the globe.

Kate Colemand

Director Quality and Compliance, PharmaLex

Kate is a Quality professional with 18 years experience in the Pharmaceutical Industry across several platforms including Biologics, Sterile Fill Finish, High Potency oncology and Solid Oral Dose products. Kate is an SME in Quality Risk Management and works with her clients to deliver and remediate QRM programs providing efficiency and clarity across the product lifecycle.